Related Experiment Video
Updated: Apr 5, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Epileptic encephalopathies: Optimizing seizure control and developmental outcome.
Lara Jehi1, Elaine Wyllie1, Orrin Devinsky2
1Department of Neurology, Cleveland Clinic, Cleveland, Ohio, U.S.A.
Cognitive and developmental outcomes in epileptic encephalopathy stem from the disease itself and frequent seizures. This review explores the relationship and suggests steps to improve patient development.
Area of Science:
- Neurology
- Developmental Neuroscience
- Epilepsy Research
Background:
- Epileptic encephalopathy is associated with poor cognitive and developmental outcomes.
- The precise mechanisms linking epilepsy to developmental deficits are not fully understood.
- Frequent seizures and epileptiform discharges may contribute to neurodevelopmental impairments.
Purpose of the Study:
- To review the evidence supporting the interplay between epileptic pathology and acquired consequences on cognitive and developmental outcomes.
- To identify critical unanswered questions regarding this relationship.
- To propose actionable steps for improving developmental outcomes in patients with epileptic encephalopathy.
Main Methods:
- Literature review of existing studies on epileptic encephalopathy and neurodevelopmental outcomes.
- Critical analysis of the evidence linking seizure activity and epileptiform discharges to cognitive deficits.
- Formulation of research questions and recommendations based on current knowledge gaps.
Main Results:
- Evidence suggests a complex interplay between the underlying epileptic substrate and the effects of recurrent seizures.
- Seizure frequency and epileptiform discharge burden are significant factors influencing developmental trajectories.
- The distinction between interictal and ictal effects on neurodevelopment requires further investigation.
Conclusions:
- Improving developmental outcomes requires addressing both the primary epileptic condition and the impact of seizure activity.
- Further research is needed to elucidate the specific mechanisms driving neurodevelopmental impairments in epileptic encephalopathy.
- Implementing targeted interventions based on identified strategies may enhance patient development.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists